A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target

Antibodies that can neutralize diverse HIV-1 strains develop in ~10–20% of HIV-1 infected individuals, and their elicitation is a goal of vaccine design. Such antibodies can also serve as therapeutics for those who have already been infected with the virus. Structural characterizations of broadly re...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker Miller, Emma, Finkelstein, Maxwell T., Erdman, Molly C., Seth, Paul C., Fera, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472920/
https://www.ncbi.nlm.nih.gov/pubmed/34578355
http://dx.doi.org/10.3390/v13091774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472920/
https://www.ncbi.nlm.nih.gov/pubmed/34578355
http://dx.doi.org/10.3390/v13091774

Ejemplares similares